ZOPHREN Side Effects

6956418-6 | Bilirubin Conjugated Increased, Blood Bilirubin Increased, Cytolytic Hepatitis, Hepatic Steatosis, Jaundice
on Aug 18, 2010 Female patient from FRANCE , weighting 294.1 lb, was diagnosed with vomiting, hypothyroidism and was treated with Zophren (View Usage). Patient experienced the following unwanted or unexpected effects: bilirubin conjugated increased, blood bilirubin increased, cytolytic hepatitis, hepatic steatosis, jaundice (What is jaundice?). Zophren dosage: 8mg Per Day. During the same period patient was treated with RASBURICASE (26.6mg Cyclic) (View Rasburicase Review and Rasburicase Label ), ZAVEDOS (16mg Cyclic) (View Zavedos Review and Zavedos Label ), BELUSTINE (400mg Cyclic) (View Belustine Review and Belustine Label ), ARACYTINE (200mg Cyclic) (View Aracytine Review and Aracytine Label ), HYDREA (4000mg Cyclic) (View Hydrea Review and Hydrea Label ), EMEND (View Emend Review and Emend Label ), LEVOTHYROXINE SODIUM (100mcg Per Day) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6911047-5 | Diarrhoea, Feeling Hot, Hypotension, Malaise, Pruritus, Pyrexia, Rash Maculo-papular, Rash Vesicular
Patient was taking Zophren (View Usage). Patient had the following side effects: diarrhoea, feeling hot, hypotension, malaise, pruritus, pyrexia, rash maculo-papular, rash vesicular on Jul 29, 2010 from FRANCE Additional patient health information: Female patient , 67 years of age, . Zophren dosage: . During the same period patient was treated with BELUSTINE (View Belustine Review and Belustine Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), ZAVEDOS (View Zavedos Review and Zavedos Label ). Patient was hospitalized.

6803213-4 | Diarrhoea, Epistaxis, Palmar-plantar Erythrodysaesthesia Syndrome
Adverse event was reported on Jun 15, 2010 by a Female patient taking Zophren (View Usage) (Dosage: 8mgm2 Per Day) was diagnosed with vomiting, adenocarcinoma and. Location: FRANCE , weighting 132.3 lb, After Zophren was administered, patient had the following side effects: diarrhoea, epistaxis, palmar-plantar erythrodysaesthesia syndrome. During the same period patient was treated with AVASTIN (300mgm2 Per Day) (View Avastin Review and Avastin Label ), CAMPTOSAR (290mgm2 Per Day) (View Camptosar Review and Camptosar Label ), FLUOROURACIL (4500mgm2 Per Day) (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN CALCIUM (520mgm2 Per Day) (View Leucovorin Calcium Review and Leucovorin Calcium Label ), SOLU MEDROL (60mgm2 Per Day) (View Solu-medrol Review and Solu-medrol Label ), PROCTOLOG (View Proctolog Review and Proctolog Label ). Patient was hospitalized.

6782053-9 | Hepatocellular Injury
on Jun 09, 2010 Female patient from FRANCE , 34 years of age, was treated with Zophren (View Usage). Patient experienced the following unwanted or unexpected effects: hepatocellular injury. Zophren dosage: . During the same period patient was treated with LEXOMIL (View Lexomil Review and Lexomil Label ), NEXIUM (View Nexium Review and Nexium Label ), EMEND (View Emend Review and Emend Label ), METOPIMAZINE (View Metopimazine Review and Metopimazine Label ), SPASFON (View Spasfon Review and Spasfon Label ), DEBRIDAT (View Debridat Review and Debridat Label ), SOLUPRED (View Solupred Review and Solupred Label ), MOTILIUM (View Motilium Review and Motilium Label ). Patient was hospitalized.


6756508-7 | Diarrhoea, Epistaxis, Palmar-plantar Erythrodysaesthesia Syndrome, Platelet Count Decreased
on May 25, 2010 Female patient from FRANCE , weighting 132.3 lb, was diagnosed with vomiting, adenocarcinoma and was treated with Zophren (View Usage). Patient had the following side effects: diarrhoea, epistaxis, palmar-plantar erythrodysaesthesia syndrome, platelet count decreased. Zophren dosage: 8mgm2 Per Day. During the same period patient was treated with AVASTIN (300mgm2 Per Day) (View Avastin Review and Avastin Label ), CAMPTOSAR (290mgm2 Per Day) (View Camptosar Review and Camptosar Label ), FLUOROURACIL (4500mgm2 Per Day) (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN CALCIUM (640mgm2 Per Day) (View Leucovorin Calcium Review and Leucovorin Calcium Label ), SOLU MEDROL (60mgm2 Per Day) (View Solu-medrol Review and Solu-medrol Label ), PROCTOLOG (View Proctolog Review and Proctolog Label ). Patient was hospitalized.

6682914-5 | Hepatocellular Injury
Patient was taking Zophren (View Usage). After Zophren was administered, patient had the following side effects: hepatocellular injury on Apr 13, 2010 from FRANCE Additional patient health information: Female patient , 34 years of age, . Zophren dosage: . During the same period patient was treated with LEXOMIL (View Lexomil Review and Lexomil Label ), NEXIUM (View Nexium Review and Nexium Label ), EMEND (View Emend Review and Emend Label ), METOPIMAZINE (View Metopimazine Review and Metopimazine Label ), SPASFON (View Spasfon Review and Spasfon Label ), DEBRIDAT (View Debridat Review and Debridat Label ), SOLUPRED (View Solupred Review and Solupred Label ), MOTILIUM (View Motilium Review and Motilium Label ). Patient was hospitalized.

6643018-0 | Altered State Of Consciousness, Anaphylactic Shock, Dermatitis Exfoliative, Hypotension, Malaise, Pruritus, Rales
Adverse event was reported on Mar 08, 2010 by a Male patient taking Zophren (View Usage) (Dosage: ) . Location: FRANCE , 64 years of age, Patient experienced the following unwanted or unexpected effects: altered state of consciousness, anaphylactic shock, dermatitis exfoliative, hypotension, malaise, pruritus, rales. During the same period patient was treated with EMEND (View Emend Review and Emend Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), PRIMPERAN INJ (View Primperan Inj Review and Primperan Inj Label ). Patient was hospitalized.

6581482-6 | Ataxia, Cerebellar Syndrome
on Feb 03, 2010 Female patient from FRANCE , weighting 114.6 lb, was diagnosed with prophylaxis and was treated with Zophren (View Usage). Patient had the following side effects: ataxia (What is ataxia?), cerebellar syndrome. Zophren dosage: . During the same period patient was treated with ARACYTINE (200mgm2 Per Day) (View Aracytine Review and Aracytine Label ), CARDIOXANE (1000mgm2 Per Day) (View Cardioxane Review and Cardioxane Label ). Patient was hospitalized.

6578266-1 | Diplopia, Epilepsy, Leukodystrophy, Pupils Unequal
on Feb 01, 2010 Male patient from FRANCE , child 7 years of age, was treated with Zophren (View Usage). After Zophren was administered, patient had the following side effects: diplopia, epilepsy (What is epilepsy?), leukodystrophy, pupils unequal. Zophren dosage: . During the same period patient was treated with METHOTREXATE (12000mgm2 Cyclic) (View Methotrexate Review and Methotrexate Label ), VEPESID (75mgm2 Cyclic) (View Vepesid Review and Vepesid Label ), ENDOXAN (3000mgm2 Cyclic) (View Endoxan Review and Endoxan Label ), BACTRIM (View Bactrim Review and Bactrim Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ). Patient was hospitalized.

6461078-7 | Leukopenia
Patient was taking Zophren (View Usage). Patient experienced the following unwanted or unexpected effects: leukopenia on Nov 23, 2009 from FRANCE Additional patient health information: Male patient , 58 years of age, . Zophren dosage: 4mg Per Day. During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), LOVENOX (View Lovenox Review and Lovenox Label ), SPASFON (View Spasfon Review and Spasfon Label ), PERFALGAN (1g Four Times Per Day) (View Perfalgan Review and Perfalgan Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), XYLOCAINE (View Xylocaine Review and Xylocaine Label ). Patient was hospitalized.

6461071-4 | Agitation, Cardio-respiratory Arrest, Cyanosis, Diarrhoea, Dyspnoea, Malaise, Pallor, Somnolence
Adverse event was reported on Nov 19, 2009 by a Male patient taking Zophren (View Usage) (Dosage: ) was diagnosed with brain neoplasm and. Location: FRANCE , child 1 years of age, Patient had the following side effects: agitation, cardio-respiratory arrest, cyanosis, diarrhoea, dyspnoea, malaise, pallor, somnolence. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), VOGALENE (View Vogalene Review and Vogalene Label ). Patient was hospitalized.

6432844-9 | Rash Papular, Toxic Skin Eruption
on Oct 30, 2009 Female patient from FRANCE , 62 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Zophren (View Usage). After Zophren was administered, patient had the following side effects: rash papular, toxic skin eruption. Zophren dosage: . During the same period patient was treated with EPIRUBICIN (160mg Cyclic) (View Epirubicin Review and Epirubicin Label ), CYCLOPHOSPHAMIDE (780mg Cyclic) (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUOROURACIL (780mg Cyclic) (View Fluorouracil Review and Fluorouracil Label ), METHYLPREDNISOLONE 4MG TAB (60mg Cyclic) (View Methylprednisolone 4mg Tab Review and Methylprednisolone 4mg Tab Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ). Patient was hospitalized.

6379469-1 | Hepatitis, Hepatocellular Injury, Inflammation, Jaundice Cholestatic
on Sep 18, 2009 Female patient from FRANCE , 62 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), pancreatic neoplasm and was treated with Zophren (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?), hepatocellular injury, inflammation, jaundice cholestatic. Zophren dosage: . During the same period patient was treated with AUGMENTIN (View Augmentin Review and Augmentin Label ), GEMZAR (View Gemzar Review and Gemzar Label ). Patient was hospitalized.

6349301-0 | Jugular Vein Thrombosis, Superior Vena Caval Occlusion
Patient was taking Zophren (View Usage). Patient had the following side effects: jugular vein thrombosis, superior vena caval occlusion on Aug 31, 2009 from FRANCE Additional patient health information: Female patient , weighting 132.3 lb, was diagnosed with hypothyroidism and. Zophren dosage: 8mgm2 Cyclic. During the same period patient was treated with AVASTIN (285mgm2 Cyclic) (View Avastin Review and Avastin Label ), CAMPTOSAR (25mgm2 Cyclic) (View Camptosar Review and Camptosar Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), FOLINATE DE CALCIUM (660mgm2 Cyclic) (View Folinate De Calcium Review and Folinate De Calcium Label ), SOLU MEDROL (60mgm2 Cyclic) (View Solu-medrol Review and Solu-medrol Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6332788-7 | Depressed Level Of Consciousness, Hemiplegia, Partial Seizures
Adverse event was reported on Aug 20, 2009 by a Male patient taking Zophren (View Usage) (Dosage: 8mg Cyclic) . Location: FRANCE , 61 years of age, After Zophren was administered, patient had the following side effects: depressed level of consciousness, hemiplegia, partial seizures. During the same period patient was treated with PLATINUM SALT (View Platinum Salt Review and Platinum Salt Label ), TAXOTERE (View Taxotere Review and Taxotere Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ).

6301501-1 | Jugular Vein Thrombosis, Superior Vena Caval Occlusion
on Jul 29, 2009 Female patient from FRANCE , weighting 132.3 lb, was diagnosed with hypothyroidism and was treated with Zophren (View Usage). Patient experienced the following unwanted or unexpected effects: jugular vein thrombosis, superior vena caval occlusion. Zophren dosage: 8mgm2 Cyclic. During the same period patient was treated with AVASTIN (285mgm2 Cyclic) (View Avastin Review and Avastin Label ), CAMPTOSAR (25mgm2 Cyclic) (View Camptosar Review and Camptosar Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), FOLINATE DE CALCIUM (660mgm2 Cyclic) (View Folinate De Calcium Review and Folinate De Calcium Label ), SOLU MEDROL (60mgm2 Cyclic) (View Solu-medrol Review and Solu-medrol Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ). Patient was hospitalized.

6100026-6 | Eosinophilia, Pruritus, Rash Maculo-papular, Rash Papular, Skin Necrosis, Toxic Skin Eruption
on Feb 20, 2009 Male patient from FRANCE , 74 years of age, was diagnosed with vomiting and was treated with Zophren (View Usage). Patient had the following side effects: eosinophilia, pruritus, rash maculo-papular, rash papular, skin necrosis, toxic skin eruption. Zophren dosage: 8mg Per Day. During the same period patient was treated with EMEND (View Emend Review and Emend Label ), VAXIGRIP (View Vaxigrip Review and Vaxigrip Label ), NEBIVOLOL (View Nebivolol Review and Nebivolol Label ), AMARYL (View Amaryl Review and Amaryl Label ), LASIX (View Lasix Review and Lasix Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ). Patient was hospitalized.

6097206-5 | Blood Alkaline Phosphatase Increased, Cholestasis, Gamma-glutamyltransferase Increased, Lipase Increased, Transaminases Increased
Patient was taking Zophren (View Usage). After Zophren was administered, patient had the following side effects: blood alkaline phosphatase increased, cholestasis, gamma-glutamyltransferase increased, lipase increased, transaminases increased on Feb 18, 2009 from FRANCE Additional patient health information: Male patient , 65 years of age, was diagnosed with prophylaxis and. Zophren dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), EMEND (View Emend Review and Emend Label ), GRANOCYTE (View Granocyte Review and Granocyte Label ), CORTICOIDS (View Corticoids Review and Corticoids Label ). Patient was hospitalized.

6077328-5 | Eosinophilia, Pruritus, Rash Maculo-papular, Rash Papular
Adverse event was reported on Feb 04, 2009 by a Male patient taking Zophren (View Usage) (Dosage: 8mg Per Day) was diagnosed with vomiting and. Location: FRANCE , 74 years of age, Patient experienced the following unwanted or unexpected effects: eosinophilia, pruritus, rash maculo-papular, rash papular. During the same period patient was treated with EMEND (View Emend Review and Emend Label ), VAXIGRIP (View Vaxigrip Review and Vaxigrip Label ), NEBIVOLOL (View Nebivolol Review and Nebivolol Label ), AMARYL (View Amaryl Review and Amaryl Label ), LASILIX (View Lasilix Review and Lasilix Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ). Patient was hospitalized.

6077317-0 | Confusional State, Movement Disorder, Toxic Encephalopathy
on Feb 11, 2009 Male patient from FRANCE , 69 years of age, was treated with Zophren (View Usage). Patient had the following side effects: confusional state, movement disorder (What is movement disorder?), toxic encephalopathy. Zophren dosage: 8mg Twice Per Day. During the same period patient was treated with OXALIPLATINE (130mg Per Day) (View Oxaliplatine Review and Oxaliplatine Label ), AVASTIN (275mg Per Day) (View Avastin Review and Avastin Label ), FLUOROURACIL (3100mg Per Day) (View Fluorouracil Review and Fluorouracil Label ), SOLU MEDROL (40mg Per Day) (View Solu-medrol Review and Solu-medrol Label ), CALCIUM LEVOFOLINATE (170mg Per Day) (View Calcium Levofolinate Review and Calcium Levofolinate Label ). Patient was hospitalized.

6075465-2 | Confusional State, Movement Disorder, Toxic Encephalopathy
on Feb 11, 2009 Male patient from FRANCE , 69 years of age, was treated with Zophren (View Usage). After Zophren was administered, patient had the following side effects: confusional state, movement disorder (What is movement disorder?), toxic encephalopathy. Zophren dosage: 8mg Twice Per Day. During the same period patient was treated with OXALIPLATINE (130mg Per Day) (View Oxaliplatine Review and Oxaliplatine Label ), AVASTIN (275mg Per Day) (View Avastin Review and Avastin Label ), FLUOROURACIL (3100mg Per Day) (View Fluorouracil Review and Fluorouracil Label ), SOLU MEDROL (40mg Per Day) (View Solu-medrol Review and Solu-medrol Label ), CALCIUM LEVOFOLINATE (170mg Per Day) (View Calcium Levofolinate Review and Calcium Levofolinate Label ). Patient was hospitalized.

6062983-6 | Blood Pressure Decreased, Hypersensitivity, Loss Of Consciousness, Malaise, Pallor, Prurigo, Tonic Clonic Movements
Patient was taking Zophren (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, hypersensitivity, loss of consciousness, malaise, pallor, prurigo, tonic clonic movements on Jan 23, 2009 from FRANCE Additional patient health information: Male patient , 61 years of age, was diagnosed with allergy prophylaxis and. Zophren dosage: 3mg Single Dose. During the same period patient was treated with CETUXIMAB (480mg Single Dose) (View Cetuximab Review and Cetuximab Label ), POLARAMINE (5mg Single Dose) (View Polaramine Review and Polaramine Label ). Patient was hospitalized.

6061655-1 | Diplopia, Epilepsy, Leukodystrophy, Pupils Unequal
Adverse event was reported on Jan 22, 2009 by a Male patient taking Zophren (View Usage) (Dosage: ) . Location: FRANCE , child 7 years of age, Patient had the following side effects: diplopia, epilepsy (What is epilepsy?), leukodystrophy, pupils unequal. During the same period patient was treated with METHOTREXATE (12000mgm2 Cyclic) (View Methotrexate Review and Methotrexate Label ), VEPESID (75mgm2 Cyclic) (View Vepesid Review and Vepesid Label ), ENDOXAN (3000mgm2 Cyclic) (View Endoxan Review and Endoxan Label ), BACTRIM (View Bactrim Review and Bactrim Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ). Patient was hospitalized.

6059055-3 | Dyspnoea, Erythema, Oropharyngeal Discomfort
on Jan 19, 2009 Female patient from FRANCE , 60 years of age, was diagnosed with prophylaxis and was treated with Zophren (View Usage). After Zophren was administered, patient had the following side effects: dyspnoea, erythema, oropharyngeal discomfort. Zophren dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), POLARAMINE (View Polaramine Review and Polaramine Label ). Patient was hospitalized.

6059054-1 | Pruritus, Rash, Toxic Skin Eruption
on Jan 19, 2009 Female patient from FRANCE , 47 years of age, was treated with Zophren (View Usage). Patient experienced the following unwanted or unexpected effects: pruritus, rash (What is rash?), toxic skin eruption. Zophren dosage: 8mg Per Day. During the same period patient was treated with ATROPINE (.25mg Per Day) (View Atropine Review and Atropine Label ), AVASTIN (260mg Per Day) (View Avastin Review and Avastin Label ), CAMPTOSAR (280mg Per Day) (View Camptosar Review and Camptosar Label ), FLUOROURACIL (640kiu Per Day) (View Fluorouracil Review and Fluorouracil Label ), ELVORINE (320mg Per Day) (View Elvorine Review and Elvorine Label ). Patient was hospitalized.

6059049-8 | Hepatitis Acute, Transaminases Increased
Patient was taking Zophren (View Usage). Patient had the following side effects: hepatitis acute, transaminases increased on Jan 19, 2009 from FRANCE Additional patient health information: Male patient , 44 years of age, was diagnosed with prophylaxis, venous thrombosis, pain (What is pain?) and. Zophren dosage: 8mg Per Day. During the same period patient was treated with PLITICAN (100mg Per Day) (View Plitican Review and Plitican Label ), INNOHEP (View Innohep Review and Innohep Label ), ZAMUDOL (100mg Three Times Per Day) (View Zamudol Review and Zamudol Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ). Patient was hospitalized.

6059048-6 | Cardiac Arrest
Adverse event was reported on Jan 19, 2009 by a Male patient taking Zophren (View Usage) (Dosage: 8mg Per Day) . Location: FRANCE , 75 years of age, After Zophren was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?). During the same period patient was treated with VIDAZA (75mgm2 Per Day) (View Vidaza Review and Vidaza Label ), CORDARONE (100mg Per Day) (View Cordarone Review and Cordarone Label ), TAHOR (View Tahor Review and Tahor Label ), KARDEGIC (75mg Per Day) (View Kardegic Review and Kardegic Label ).

6059046-2 | Blood Alkaline Phosphatase Increased, Cholestasis, Gamma-glutamyltransferase Increased, Lipase Increased, Transaminases Increased
on Jan 19, 2009 Male patient from FRANCE , 65 years of age, was diagnosed with prophylaxis and was treated with Zophren (View Usage). Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, cholestasis, gamma-glutamyltransferase increased, lipase increased, transaminases increased. Zophren dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), EMEND (View Emend Review and Emend Label ), GRANOCYTE (View Granocyte Review and Granocyte Label ), CORTICOIDS (View Corticoids Review and Corticoids Label ). Patient was hospitalized.

6053332-8 | Asthmatic Crisis, Oxygen Saturation Decreased, Urticaria
on Jan 16, 2009 Female patient from FRANCE , 17 years of age, was diagnosed with pain (What is pain?) and was treated with Zophren (View Usage). Patient had the following side effects: asthmatic crisis, oxygen saturation decreased, urticaria. Zophren dosage: 8mg Per Day. During the same period patient was treated with ASPARAGINASE (View Asparaginase Review and Asparaginase Label ), NUBAIN (View Nubain Review and Nubain Label ), METHOTREXATE (1340mg Per Day) (View Methotrexate Review and Methotrexate Label ), VINCRISTINE (2mg Per Day) (View Vincristine Review and Vincristine Label ), FLUCONAZOLE (130mg Per Day) (View Fluconazole Review and Fluconazole Label ), DECTANCYL (13.5mg Per Day) (View Dectancyl Review and Dectancyl Label ), BEVITINE (100mg Per Day) (View Bevitine Review and Bevitine Label ), PYRIDOXINE (View Pyridoxine Review and Pyridoxine Label ).

6053331-6 | Arrhythmia, Supraventricular Extrasystoles, Ventricular Tachycardia
Patient was taking Zophren (View Usage). After Zophren was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), supraventricular extrasystoles, ventricular tachycardia on Jan 19, 2009 from FRANCE Additional patient health information: Male patient , 80 years of age, was diagnosed with pain (What is pain?) and. Zophren dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CAMPTOSAR (View Camptosar Review and Camptosar Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), SECTRAL (200mg Per Day) (View Sectral Review and Sectral Label ), INIPOMP (View Inipomp Review and Inipomp Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), IXPRIM (6unit Per Day) (View Ixprim Review and Ixprim Label ).

6048502-9 | Anaphylactic Shock, Blood Pressure Decreased, Cyanosis, Loss Of Consciousness, Malaise
Adverse event was reported on Jan 20, 2009 by a Female patient taking Zophren (View Usage) (Dosage: 8mg Per Day) . Location: FRANCE , 62 years of age, Patient experienced the following unwanted or unexpected effects: anaphylactic shock, blood pressure decreased, cyanosis, loss of consciousness, malaise. During the same period patient was treated with RANIPLEX (50mg Per Day) (View Raniplex Review and Raniplex Label ), PACLITAXEL (250mg Per Day) (View Paclitaxel Review and Paclitaxel Label ), SOLU MEDROL (120mg Per Day) (View Solu-medrol Review and Solu-medrol Label ), POLARAMINE (5mg Per Day) (View Polaramine Review and Polaramine Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ).

6015902-2 | Abdominal Pain, C-reactive Protein Increased, Colitis Ischaemic, Hypokalaemia, Rectal Haemorrhage
on Dec 15, 2008 Female patient from FRANCE , 68 years of age, was treated with Zophren (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), c-reactive protein increased, colitis ischaemic, hypokalaemia, rectal haemorrhage. Zophren dosage: 8mg Per Day. During the same period patient was treated with DETICENE (396mg Per Day) (View Deticene Review and Deticene Label ), BICNU (216mg Single Dose) (View Bicnu Review and Bicnu Label ), CISPLATIN (45mg Per Day) (View Cisplatin Review and Cisplatin Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ). Patient was hospitalized.

6013734-2 | Abortion Induced
on Dec 09, 2008 Female patient from FRANCE , 29 years of age, weighting 110.2 lb, was diagnosed with vomiting in pregnancy and was treated with Zophren (View Usage). After Zophren was administered, patient had the following side effects: abortion induced. Zophren dosage: 3amp Per Day. During the same period patient was treated with VOGALENE (View Vogalene Review and Vogalene Label ).

6000069-7 | Oropharyngeal Blistering, Prurigo, Renal Failure Acute, Skin Disorder, Stevens-johnson Syndrome, Toxic Epidermal Necrolysis, Toxic Skin Eruption
Patient was taking Zophren (View Usage). Patient experienced the following unwanted or unexpected effects: oropharyngeal blistering, prurigo, renal failure acute, skin disorder, stevens-johnson syndrome, toxic epidermal necrolysis, toxic skin eruption on Dec 04, 2008 from FRANCE Additional patient health information: Female patient , 66 years of age, was diagnosed with agranulocytosis, fungal infection (What is fungal infection?), lung adenocarcinoma metastatic, pain (What is pain?) and. Zophren dosage: 16mg Per Day. During the same period patient was treated with TIENAM (3000mg Per Day) (View Tienam Review and Tienam Label ), TRIFLUCAN (100mg Twice Per Day) (View Triflucan Review and Triflucan Label ), ALIMTA (950mg Per Day) (View Alimta Review and Alimta Label ), PRIMPERAN TAB (30mg Per Day) (View Primperan Tab Review and Primperan Tab Label ), FUNGIZONE (View Fungizone Review and Fungizone Label ), AMLOD (View Amlod Review and Amlod Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), ADVIL LIQUI GELS (1unit Twice Per Day) (View Advil Liqui-gels Review and Advil Liqui-gels Label ). Patient was hospitalized.

5981194-3 | Confusional State, Movement Disorder, Toxic Encephalopathy
Adverse event was reported on Nov 24, 2008 by a Male patient taking Zophren (View Usage) (Dosage: 160mg Per Day) . Location: FRANCE , 69 years of age, Patient had the following side effects: confusional state, movement disorder (What is movement disorder?), toxic encephalopathy. During the same period patient was treated with OXALIPLATINE (130mg Per Day) (View Oxaliplatine Review and Oxaliplatine Label ), AVASTIN (275mg Per Day) (View Avastin Review and Avastin Label ), FLUOROURACIL (3100mg Per Day) (View Fluorouracil Review and Fluorouracil Label ), SOLU MEDROL (40mg Per Day) (View Solu-medrol Review and Solu-medrol Label ), LEUCOVORIN CALCIUM (170mg Per Day) (View Leucovorin Calcium Review and Leucovorin Calcium Label ). Patient was hospitalized.

5972536-3 | Headache, Hypertension, Myodesopsia, Visual Field Defect, Visual Impairment
on Nov 18, 2008 Female patient from FRANCE , 61 years of age, was diagnosed with intestinal adenocarcinoma and was treated with Zophren (View Usage). After Zophren was administered, patient had the following side effects: headache (What is headache?), hypertension, myodesopsia, visual field defect, visual impairment. Zophren dosage: 1amp Single Dose. During the same period patient was treated with CETUXIMAB (650mg Single Dose) (View Cetuximab Review and Cetuximab Label ), CAMPTOSAR (295mg Single Dose) (View Camptosar Review and Camptosar Label ), FOLINATE OF CALCIUM (650mg Single Dose) (View Folinate Of Calcium Review and Folinate Of Calcium Label ), FLUOROURACIL (650mg Single Dose) (View Fluorouracil Review and Fluorouracil Label ), POLARAMINE (1amp Single Dose) (View Polaramine Review and Polaramine Label ). Patient was hospitalized.

5972535-1 | Blister, Erythema, Myalgia, Pain In Extremity, Rash Erythematous, Skin Exfoliation
on Nov 17, 2008 Female patient from FRANCE , 49 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Zophren (View Usage). Patient experienced the following unwanted or unexpected effects: blister, erythema, myalgia, pain in extremity, rash erythematous, skin exfoliation. Zophren dosage: . During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), HERCEPTIN (View Herceptin Review and Herceptin Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), TENSTATEN (View Tenstaten Review and Tenstaten Label ), LOXEN LP 50 MG (View Loxen Lp 50 Mg Review and Loxen Lp 50 Mg Label ).

5972534-X | Acidosis, Bronchospasm, Hypercapnia, Hypotension, Hypoxia, Psychomotor Retardation, Rales
Patient was taking Zophren (View Usage). Patient had the following side effects: acidosis, bronchospasm, hypercapnia, hypotension, hypoxia, psychomotor retardation, rales on Nov 17, 2008 from FRANCE Additional patient health information: Female patient , 50 years of age, . Zophren dosage: 8mg Single Dose. During the same period patient was treated with PERFUSION (View Perfusion Review and Perfusion Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), NOZINAN (View Nozinan Review and Nozinan Label ). Patient was hospitalized.

5972533-8 | Diplopia, Dizziness
Adverse event was reported on Nov 17, 2008 by a Male patient taking Zophren (View Usage) (Dosage: 8mg Per Day) . Location: FRANCE , 69 years of age, After Zophren was administered, patient had the following side effects: diplopia, dizziness (What is dizziness?). During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ). Patient was hospitalized.

5948499-3 | Chills, Dyspnoea, Hypoxia, Intercostal Retraction, Interstitial Lung Disease, Lung Infiltration, Pericardial Effusion, Pyrexia, Skin Discolouration
on Oct 31, 2008 Male patient from FRANCE , 74 years of age, was treated with Zophren (View Usage). Patient experienced the following unwanted or unexpected effects: chills, dyspnoea, hypoxia, intercostal retraction, interstitial lung disease, lung infiltration, pericardial effusion, pyrexia, skin discolouration. Zophren dosage: . During the same period patient was treated with ARSENIC TRIOXID (12mg Per Day) (View Arsenic Trioxid Review and Arsenic Trioxid Label ), ZAVEDOS (18mg Per Day) (View Zavedos Review and Zavedos Label ), GRANOCYTE (View Granocyte Review and Granocyte Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), OFLOCET (View Oflocet Review and Oflocet Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), BRICANYL (View Bricanyl Review and Bricanyl Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

5946517-X | Dysphagia, Hypoaesthesia Oral, Pruritus, Rash, Tongue Oedema, Urticaria
on Oct 29, 2008 Female patient from FRANCE , 68 years of age, was diagnosed with colon cancer and was treated with Zophren (View Usage). Patient had the following side effects: dysphagia, hypoaesthesia oral, pruritus, rash (What is rash?), tongue oedema, urticaria. Zophren dosage: . During the same period patient was treated with ELOXATIN (View Eloxatin Review and Eloxatin Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized.

5946515-6 | Diplopia, Epilepsy, Leukodystrophy, Pupils Unequal
Patient was taking Zophren (View Usage). After Zophren was administered, patient had the following side effects: diplopia, epilepsy (What is epilepsy?), leukodystrophy, pupils unequal on Oct 29, 2008 from FRANCE Additional patient health information: Male patient , child 7 years of age, . Zophren dosage: . During the same period patient was treated with METHOTREXATE (1200mgm2 Per Day) (View Methotrexate Review and Methotrexate Label ), VEPESID (75mgm2 Per Day) (View Vepesid Review and Vepesid Label ), ENDOXAN (300mgm2 Per Day) (View Endoxan Review and Endoxan Label ), BACTRIM (View Bactrim Review and Bactrim Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ). Patient was hospitalized.

5929543-6 | Bronchitis, Dyspnoea, Hypoxia, Lung Disorder, Mediastinal Disorder, Obstructive Airways Disorder, Pulmonary Fibrosis, Respiratory Distress
Adverse event was reported on Oct 16, 2008 by a Female patient taking Zophren (View Usage) (Dosage: 8mg Per Day) was diagnosed with breast cancer (What is breast cancer?) and. Location: FRANCE , 80 years of age, Patient experienced the following unwanted or unexpected effects: bronchitis (What is bronchitis?), dyspnoea, hypoxia, lung disorder, mediastinal disorder, obstructive airways disorder, pulmonary fibrosis (What is pulmonary fibrosis?), respiratory distress. During the same period patient was treated with ENDOXAN (825mg Per Day) (View Endoxan Review and Endoxan Label ), FLUOROURACIL (825mg Per Day) (View Fluorouracil Review and Fluorouracil Label ), SOLU MEDROL (60mg Per Day) (View Solu-medrol Review and Solu-medrol Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), TAXOTERE (120mg Per Day) (View Taxotere Review and Taxotere Label ), EUPRESSYL (View Eupressyl Review and Eupressyl Label ). Patient was hospitalized.

5928084-X | Dermatitis Bullous, Oral Disorder, Pruritus, Skin Necrosis
on Oct 13, 2008 Female patient from FRANCE , 44 years of age, was treated with Zophren (View Usage). Patient had the following side effects: dermatitis bullous, oral disorder, pruritus, skin necrosis. Zophren dosage: 3mg Per Day. During the same period patient was treated with BUSULFAN (View Busulfan Review and Busulfan Label ), THIOTEPA (View Thiotepa Review and Thiotepa Label ), TOPALGIC (FRANCE) (View Topalgic (france) Review and Topalgic (france) Label ), RIVOTRIL (1mg Per Day) (View Rivotril Review and Rivotril Label ). Patient was hospitalized.

5916533-2 | Apnoea, Convulsion, Depressed Level Of Consciousness, Dyspnoea, Eye Disorder, Intercostal Retraction, Respiratory Arrest, Somnolence, Unresponsive To Stimuli
on Oct 03, 2008 Female patient from FRANCE , weighting 13.01 lb, was diagnosed with vomiting, retinoblastoma and was treated with Zophren (View Usage). After Zophren was administered, patient had the following side effects: apnoea, convulsion, depressed level of consciousness, dyspnoea, eye disorder, intercostal retraction, respiratory arrest, somnolence, unresponsive to stimuli. Zophren dosage: . During the same period patient was treated with VINCRISTINE (.2mg Single Dose) (View Vincristine Review and Vincristine Label ), PLITICAN (View Plitican Review and Plitican Label ), ENDOXAN (40mg Single Dose) (View Endoxan Review and Endoxan Label ).

5908728-9 | Cardiac Tamponade, Hepatic Function Abnormal, Left Ventricular Dysfunction, Pericardial Effusion, Renal Impairment
Patient was taking Zophren (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac tamponade, hepatic function abnormal, left ventricular dysfunction, pericardial effusion, renal impairment on Sep 25, 2008 from FRANCE Additional patient health information: Male patient , 60 years of age, . Zophren dosage: 8mg Per Day. During the same period patient was treated with ENDOXAN (1.5g Per Day) (View Endoxan Review and Endoxan Label ), DOXORUBICIN HCL (100mg Per Day) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), UROMITEXAN IV (500mg Per Day) (View Uromitexan Iv Review and Uromitexan Iv Label ), VINCRISTINE (2mg Per Day) (View Vincristine Review and Vincristine Label ), CORTANCYL (80mg Per Day) (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

5908727-7 | Eosinophil Count Increased, Erythema Multiforme, Toxic Skin Eruption
Adverse event was reported on Sep 25, 2008 by a Male patient taking Zophren (View Usage) (Dosage: 4mg Three Times Per Day) . Location: FRANCE , 50 years of age, Patient had the following side effects: eosinophil count increased, erythema multiforme, toxic skin eruption. During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), SKENAN (View Skenan Review and Skenan Label ), MORPHINE (40mg Per Day) (View Morphine Review and Morphine Label ), PROPOXYPHENE HCL AND ACETAMINOPHEN (2u Three Times Per Day) (View Propoxyphene Hcl And Acetaminophen Review and Propoxyphene Hcl And Acetaminophen Label ), TARGOCID (800mg Twice Per Day) (View Targocid Review and Targocid Label ), BRISTOPEN (2g Six Times Per Day) (View Bristopen Review and Bristopen Label ), RIFADIN (900mg Twice Per Day) (View Rifadin Review and Rifadin Label ), ATARAX (100mg Per Day) (View Atarax Review and Atarax Label ). Patient was hospitalized.

5889627-8 | Scleroderma
on Sep 10, 2008 Male patient from FRANCE , 69 years of age, was treated with Zophren (View Usage). After Zophren was administered, patient had the following side effects: scleroderma (What is scleroderma?). Zophren dosage: . During the same period patient was treated with DETICENE (View Deticene Review and Deticene Label ), VELBE (View Velbe Review and Velbe Label ), ADRIBLASTINE (View Adriblastine Review and Adriblastine Label ), BLEOMYCINE (View Bleomycine Review and Bleomycine Label ), SOLU MEDROL (120mg Per Day) (View Solu-medrol Review and Solu-medrol Label ), PLITICAN (View Plitican Review and Plitican Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), ANAUSIN (View Anausin Review and Anausin Label ). Patient was hospitalized.

5889626-6 | Bradypnoea, Cardio-respiratory Arrest, Loss Of Consciousness
on Sep 10, 2008 Female patient from FRANCE , weighting 13.01 lb, was treated with Zophren (View Usage). Patient experienced the following unwanted or unexpected effects: bradypnoea, cardio-respiratory arrest, loss of consciousness. Zophren dosage: .

5889619-9 | Erythema, Feeling Hot, Hypersensitivity, Nausea, Rash
Patient was taking Zophren (View Usage). Patient had the following side effects: erythema, feeling hot, hypersensitivity, nausea (What is nausea?), rash (What is rash?) on Sep 10, 2008 from FRANCE Additional patient health information: Female patient , 56 years of age, . Zophren dosage: 8mg Per Day. During the same period patient was treated with AVASTIN (630mg Per Day) (View Avastin Review and Avastin Label ), CARBOPLATIN (340mg Per Day) (View Carboplatin Review and Carboplatin Label ), PLITICAN (50mg Per Day) (View Plitican Review and Plitican Label ), SOLU MEDROL (60mg Per Day) (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized.